These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 27506989)

  • 21. Prognostic factors of distal cholangiocarcinoma after curative surgery: a series of 84 cases.
    Tan X; Xiao K; Liu W; Chang S; Zhang T; Tang H
    Hepatogastroenterology; 2013; 60(128):1892-5. PubMed ID: 24719923
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Lymphovascular and perineural invasion as selection criteria for adjuvant therapy in intrahepatic cholangiocarcinoma: a multi-institution analysis.
    Fisher SB; Patel SH; Kooby DA; Weber S; Bloomston M; Cho C; Hatzaras I; Schmidt C; Winslow E; Staley CA; Maithel SK
    HPB (Oxford); 2012 Aug; 14(8):514-22. PubMed ID: 22762399
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prognostic factors for survival after curative resection of distal cholangiocarcinoma: perineural invasion and lymphovascular invasion.
    Kim HJ; Kim CY; Hur YH; Koh YS; Kim JC; Kim HJ; Cho CK
    Surg Today; 2014 Oct; 44(10):1879-86. PubMed ID: 24535697
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Intrahepatic, peri-hilar and distal cholangiocarcinoma: Three different locations of the same tumor or three different tumors?
    Ercolani G; Dazzi A; Giovinazzo F; Ruzzenente A; Bassi C; Guglielmi A; Scarpa A; D'Errico A; Pinna AD
    Eur J Surg Oncol; 2015 Sep; 41(9):1162-9. PubMed ID: 26095704
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Validation of the T category for distal cholangiocarcinoma: Measuring the depth of invasion is complex but correlates with survival.
    Park JY; Kim SY; Shin DH; Choi KU; Kim JY; Sol MY; Lee HJ; Hwang C; Ryu JH; Yang KH; Lee TB; Lee JH
    Ann Diagn Pathol; 2020 Jun; 46():151489. PubMed ID: 32169826
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prognostic factors and long-term outcomes of hilar cholangiocarcinoma: A single-institution experience in China.
    Hu HJ; Mao H; Shrestha A; Tan YQ; Ma WJ; Yang Q; Wang JK; Cheng NS; Li FY
    World J Gastroenterol; 2016 Feb; 22(8):2601-10. PubMed ID: 26937148
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pancreatoduodenectomy with portal vein resection for distal cholangiocarcinoma.
    Maeta T; Ebata T; Hayashi E; Kawahara T; Mizuno S; Matsumoto N; Ohta S; Nagino M;
    Br J Surg; 2017 Oct; 104(11):1549-1557. PubMed ID: 28782798
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparison of the prognostic accuracy of the sixth and seventh editions of the TNM classification for intrahepatic cholangiocarcinoma.
    Ribero D; Nuzzo G; Amisano M; Tomatis M; Guglielmi A; Giulini SM; Aldrighetti L; Calise F; Gerunda GE; Pinna AD; Capussotti L;
    HPB (Oxford); 2011 Mar; 13(3):198-205. PubMed ID: 21309938
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Confinement to the intrapancreatic bile duct is independently associated with a better prognosis in extrahepatic cholangiocarcinoma.
    Ahn KS; Kang KJ; Kang YN; Kim YH; Kim TS
    BMC Gastroenterol; 2016 Feb; 16():21. PubMed ID: 26911927
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Serum CYFRA 21-1 in Biliary Tract Cancers: A Reliable Biomarker for Gallbladder Carcinoma and Intrahepatic Cholangiocarcinoma.
    Huang L; Chen W; Liang P; Hu W; Zhang K; Shen S; Chen J; Zhang Z; Chen B; Han Y; Meng F; DeMorrow S; Yin X; Lai J; Liang L
    Dig Dis Sci; 2015 May; 60(5):1273-83. PubMed ID: 25487191
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prognostic value of lymph nodes count on survival of patients with distal cholangiocarcinomas.
    Lin HP; Li SW; Liu Y; Zhou SJ
    World J Gastroenterol; 2018 Mar; 24(9):1022-1034. PubMed ID: 29531466
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Validation of the Eighth American Joint Committee on Cancer Staging System for Distal Bile Duct Carcinoma.
    Jun SY; Sung YN; Lee JH; Park KM; Lee YJ; Hong SM
    Cancer Res Treat; 2019 Jan; 51(1):98-111. PubMed ID: 29510611
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A model to predict survival following pancreaticoduodenectomy for malignancy based on tumour site, stage and lymph node ratio.
    Dasari BV; Roberts KJ; Hodson J; Stevens L; Smith AM; Hubscher SG; Isaac J; Muiesan P; Sutcliffe RP; Marudanayagam R; Mirza DF
    HPB (Oxford); 2016 Apr; 18(4):332-8. PubMed ID: 27037202
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Proposal on incorporating lymphovascular invasion as a T-descriptor for stage I lung cancer.
    Wang S; Zhang B; Qian J; Qiao R; Xu J; Zhang L; Zhao Y; Zhang Y; Wang R; Zhao R; Han B
    Lung Cancer; 2018 Nov; 125():245-252. PubMed ID: 30429028
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Proposal of a new staging system for intrahepatic cholangiocarcinoma: Analysis of surgical patients from a nationwide survey of the Liver Cancer Study Group of Japan.
    Sakamoto Y; Kokudo N; Matsuyama Y; Sakamoto M; Izumi N; Kadoya M; Kaneko S; Ku Y; Kudo M; Takayama T; Nakashima O;
    Cancer; 2016 Jan; 122(1):61-70. PubMed ID: 26430782
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Elevated NLR in gallbladder cancer and cholangiocarcinoma - making bad cancers even worse: results from the US Extrahepatic Biliary Malignancy Consortium.
    Beal EW; Wei L; Ethun CG; Black SM; Dillhoff M; Salem A; Weber SM; Tran T; Poultsides G; Son AY; Hatzaras I; Jin L; Fields RC; Buettner S; Pawlik TM; Scoggins C; Martin RC; Isom CA; Idrees K; Mogal HD; Shen P; Maithel SK; Schmidt CR
    HPB (Oxford); 2016 Nov; 18(11):950-957. PubMed ID: 27683047
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prognostic indicators following curative pancreatoduodenectomy for pancreatic carcinoma: A retrospective multivariate analysis of a single centre experience.
    Petrou A; Soonawalla Z; Silva MA; Manzelli A; Moris D; Tabet PP; Friend P
    J BUON; 2016; 21(4):874-882. PubMed ID: 27685908
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hepatitis B virus-related combined hepatocellular-cholangiocarcinoma: clinicopathological and prognostic analysis of 390 cases.
    Chu KJ; Lu CD; Dong H; Fu XH; Zhang HW; Yao XP
    Eur J Gastroenterol Hepatol; 2014 Feb; 26(2):192-9. PubMed ID: 24370644
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Serosal invasion in TNM staging of mass-forming intrahepatic cholangiocarcinoma.
    Uenishi T; Yamazaki O; Yamamoto T; Hirohashi K; Tanaka H; Tanaka S; Hai S; Kubo S
    J Hepatobiliary Pancreat Surg; 2005; 12(6):479-83. PubMed ID: 16365823
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prognostic Factors Associated with Preoperative Clinicophysiological Outcomes of Distal Cholangiocarcinoma.
    Suzuki S; Kajiyama H; Shimoda M; Shimazaki J; Koike N; Harada N
    Dig Surg; 2017; 34(6):476-482. PubMed ID: 28166534
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.